JAK Inhibitors Prior to Allogeneic Stem Cell Transplant for Patients with Myelofibrosis: A Prospective Study

被引：0
|
作者：
Salit, Rachel B. [1 ]
Stevens, Emily [2 ]
Baker, Kelsey [1 ]
Scott, Bart L. [3 ]
Gooley, Ted Alan [1 ]
Deeg, H. Joachim [4 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA
[2] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA
[3] Fred Hutchinson Canc Res Ctr, Transplantat Biol, 1124 Columbia St, Seattle, WA 98104 USA
[4] Fred Hutchinson Canc Res Ctr, Div Clin Res, Transplantat Biol Program, 1124 Columbia St, Seattle, WA 98104 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2018年 / 24卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
17
引用
收藏
页码：S33 / S33
页数：1
相关论文
共 50 条
  • [41] Myeloid Mixed Chimerism and Relapse in Myelofibrosis after Allogeneic Stem Cell Transplant
    Srour, Samer A.
    Desai, Parth
    Ciurea, Stefan O.
    Bashir, Qaiser
    Oran, Betul
    Olson, Amanda L.
    Ahmed, Sairah
    Bose, Prithviraj
    Mehta, Rohtesh S.
    Pemmaraju, Naveen
    Verstovsek, Srdan
    Champlin, Richard E.
    Popat, Uday
    BLOOD, 2017, 130
  • [42] Splenic Irradiation Prior to Allogeneic Hematopoietic Cell Transplantation for Patients with Myelofibrosis
    Bales, John R.
    Kim, Haesook T.
    Portillo, Roxana
    Patel, Chirayu
    McAfee, Steven
    Dey, Bimalangshu
    Spitzer, Thomas
    Chen, Yi-Bin
    El-Jawahri, Areej
    Defilipp, Zachariah
    Hobbs, Gabriela S.
    BLOOD, 2022, 140 : 12957 - 12958
  • [43] Diagnostic driven antifungal strategy in patients submitted to allogeneic haematopoietic stem cell transplant:: a prospective study
    Girmenia, C.
    Iori, A. P.
    Gentile, G.
    Micozzi, A.
    Santilli, S.
    Ballaro, D.
    Torelli, G. F.
    Milano, F.
    Lucarelli, B.
    Arleo, E.
    Brocchieri, S.
    Guerrisi, V.
    Foa, R.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S259 - S260
  • [44] Splenic irradiation prior to allogeneic hematopoietic cell transplantation for patients with myelofibrosis
    Bales, John R. R.
    Kim, Haesook T. T.
    Portillo, Roxana
    Patel, Chirayu
    McAfee, Steven
    Dey, Bimalangshu
    Spitzer, Thomas
    Chen, Yi-Bin
    El-Jawahri, Areej
    DeFilipp, Zachariah
    Hobbs, Gabriela S. S.
    BONE MARROW TRANSPLANTATION, 2023, 58 (04) : 459 - 461
  • [45] Impact of Pre-Transplant Ruxolitinib in Myelofibrosis Patients on Outcome after Allogeneic Stem Cell Transplantation
    Abd Kadir, Sharifah Shahnaz Syed
    Zabelina, Tatjana
    Christopeit, Maximilian
    Wulf, Gerald G.
    Wagner, Eva Maria
    Bornhaeuser, Martin
    Schroeder, Thomas
    Crysandt, Martina
    Mayer, Karin
    Stelljes, Matthias
    Badbaran, Anita
    Wolschke, Christine
    Ayuk, Francis A.
    Triviai, Ioanna N.
    Wolf, Dominik
    Kroeger, Nicolaus
    BLOOD, 2016, 128 (22)
  • [46] Impact of pre-transplant ruxolitinib in myelofibrosis patients on outcome after allogeneic stem cell transplantation
    Abd Kadir, Syed
    Shahnaz, Sharifah
    Zabelina, Tatjana
    Christopeit, Maximilian
    Wulf, Gerald
    Wagner, Eva
    Bornhaeuser, Martin
    Schroeder, Thomas
    Crysandt, Martina
    Mayer, Karin Tina
    Stelljes, Matthias
    Badbaran, Anita
    Wolschke, Christine
    Ayuketang, Ayuk Francis
    Triviai, Ioanna
    Wolf, Dominik
    Kroeger, Nicolaus
    BONE MARROW TRANSPLANTATION, 2017, 52 : S423 - S423
  • [47] Allogeneic Stem Cell Transplantation in Myelofibrosis
    Jain, Tania
    Mesa, Ruben A.
    Palmer, Jeanne M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (09) : 1429 - 1436
  • [48] Reduced intensity allogeneic stem cell transplantation in patients with myelofibrosis
    Bloor, AJC
    Ahmed, O
    Dimpoulou, M
    Fielding, AK
    Chakraverty, R
    Parker, AN
    Liakopoulou, E
    Goldstone, AH
    Thomson, K
    Mackinnon, S
    Kottaridis, P
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 : 13 - 13
  • [49] Impact of Prior Jak-Inhibitor Therapy With Ruxolitinib on Outcome After Allogeneic Stem Cell Transplantation For Myelofibrosis. A Large EBMT-CMWP Study
    Kroeger, Nicolaus
    Sbianchi, Giulia
    Sirait, Tiarlan
    Beelen, Dietrich
    Passweg, Jakob
    Robin, Marie
    Vrhovac, Radovan
    Helbig, Grzegor
    Sockel, Katja
    Conneally, Eibhlin
    Rubio, Marie Therese
    Beguin, Yves
    Finke, Juergen
    Bernasconi, Paolo
    Morozova, Elena
    Clausen, Johannes
    von dem Borne, Peter
    Schaap, Nicolaas
    Schroyens, Wilfried
    Patriarca, Francesca
    Di Renzo, Nicola
    Yegin, Zeynep Arzu
    Hayden, Patrick
    McLornan, Donal
    Yakoub-Agha, Ibrahim
    BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 143 - 144
  • [50] OUTCOMES OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT) IN PATIENTS WITH MYELOFIBROSIS (MF) EXPOSED TO JAK1/2 INHIBITORS
    Shanavas, M.
    Popat, U.
    Michaelis, L. C.
    Fauble, V.
    Mclornan, D.
    Klisovic, R.
    Mascarenhas, J.
    Tamari, R.
    Arcasoy, M.
    Davies, J.
    Gergis, U.
    Ukaegbu, O.
    Kamble, R.
    Storring, J.
    Majhail, N. S.
    Romee, R.
    Lew, J.
    Pagliuca, A.
    Vasu, S.
    Ernst, B.
    Atenafu, E.
    Hanif, A.
    Champlin, R.
    Hari, P.
    Gupta, V.
    HAEMATOLOGICA, 2015, 100 : 162 - 163
12345